News

Hannes Snellman Counsel to Recipharm AB (publ) in the Divestment of the Rights to its ThyroSafe Product

15 June 2018

Hannes Snellman acted as counsel to Recipharm AB (publ) in the divestment of the rights to its potassium iodide product ThyroSafe, except for the US territory, to SERB SA.